SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 63 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $79,879,000 | +2150.1% | 30,051,000 | +1443.5% | 0.08% | +2466.7% |
| Q4 2014 | $3,550,000 | -67.3% | 1,947,000 | -56.6% | 0.00% | -66.7% |
| Q3 2014 | $10,848,000 | +6637.9% | 4,485,000 | +5369.5% | 0.01% | – |
| Q2 2014 | $161,000 | +2200.0% | 82,000 | +1540.0% | 0.00% | – |
| Q4 2013 | $7,000 | -95.7% | 5,000 | -96.3% | 0.00% | – |
| Q2 2013 | $163,000 | – | 136,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $4,916,000 | 4.33% |
| SYMPHONY ASSET MANAGEMENT LLC | 19,840,000 | $38,948,000 | 4.05% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $38,695,000 | 4.00% |
| MACKAY SHIELDS LLC | 31,471,000 | $61,916,000 | 3.41% |
| Sage Capital Management, LLC | 1,500,000 | $2,942,000 | 2.98% |
| ALTEGRIS ADVISORS, L.L.C. | 250,000 | $491,000 | 2.56% |
| Wellesley Asset Management | 16,220 | $31,923,000 | 2.01% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $16,883,000 | 1.62% |
| CAMDEN ASSET MANAGEMENT L P /CA | 13,862,000 | $27,213,000 | 1.58% |
| Calamos Wealth Management LLC | 2,061,000 | $4,045,000 | 1.15% |